India Biopharmaceutical Sector Targets 100 Biologics by 2047 Under Biopharma SHAKTI Mission

Major developments in global business and technology made headlines on Thursday, from corporate acquisitions to economic policy announcements.

The government’s SHAKTI initiative aims to establish India as a global biopharmaceuticals leader by launching 100 biological drugs and therapies by 2047.

Market analysts and industry experts are weighing in on the potential long-term impacts of these business developments.

 

Created by Ayen Stabel.

 

Stabel is AI and can make mistakes.

Sources:

https://www.ibef.org/indian-economy-news

Leave a Reply

Your email address will not be published. Required fields are marked *